Dopamine receptor D2 (DRD2) encoded by DRD2 gene, is located on chromosome 11q22-23. Dopamine plays the central role in motivation, cognition, and reward seeking behaviour. Its dysfunction is implicated in numerous neurological and psychiatric disorders including drug abuse, schizophrenia, ADHD etc. The TaqI A polymorphism is localized 9.8 kb downstream from DRD2 gene in exon 8 of protein kinase gene (ANKK1). It is a SNP demonstrated to cause Glutamate to Lysine substitution at 713 amino acid residue in putative binding domain of ANKK1. Due to the central role of dopamine in reward seeking behavior, DRD2 TaqI A loci is a suitable candidate for investigation of molecular basis of addiction.The aim of the present study is to evaluate the frequency of DRD2 TaqI A polymorphism in Eastern Uttar Pradesh population.
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Introduction:
One of the most important system intervening reward mechanisms is considered to be dopaminergic pathways. Dopaminergic neurons are present in VTA of midbrain, projected into nucleus accumbens and ventral striatum [1] All the genes, involved in regulating the assembly of this system in brain is of great interest and can be a suitable candidate for investigation of molecular basis of addiction and several other psychiatric disorders [2] . Among these, the gene of interest that effect the dopaminergic neurotransmission is the Dopamine D2 receptor (DRD2) gene that is located at chromosome 11q22-23 encoding a G-Protein coupled receptor (Giinhibitory G protein) in post synaptic neurons [3] performing dual function of inhibitory auto receptor and a post synaptic receptors [4] .
Several polymorphisms are reported in DRD2 gene (Taq1 B, Taq1D, -141 Ins/Del, Ser-Cys(S311C) but Taq1 A polymorphism is well studied in different psychiatric disorders including schizophrenia [5] , depression [6] , bipolar disorder [7] , ADHD [8] , and PTSD [9] and drug abuse [3] . TaqI A is SNP (rs1800497) located 9.8 kb downstream of DRD2 gene within exon 8 of functionally unrelated neighbouring gene, Ankyrin repeat and kinase domain containing-1(ANNK1). It causes Glutamate to Lysine substitution at 713 amino acid residue in putative binding domain of ANNK1 [10] with two alleles attributed as A1 and A2. This polymorphism leads to alteration of the activity of promoter region of DRD2 gene and also the expression of D2-type receptors [11] . Individuals with A1A1 genotype have approximately 49% reduced number of dopamine receptors than to those without A1. Less number of DRD2 receptors in nucleus accumbens and striatum increases craving for alcohol. Hence, the aim of present study is to determine the frequency of DRD2 TaqIA polymorphism in Eastern Uttar Pradesh population.
Materials and Methods
All 50 participants were recruited from Eastern Uttar Pradesh (Jaunpur) population, informed written consent was taken from each participants. Prior blood sample collection clearance certificate was taken from the Institutional Ethics Committee of VBS Purvanchal University, Jaunpur.
3 Genotyping 3 ml blood was drawn from each individual and genomic DNA was isolated by the method of Bartlett and White [12] . Polymerase chain reaction (PCR) based genotyping was done by using gene specific primers according to the method of Grandy et al. [13] . The reaction conditions were enlisted in table 1. Restriction Taq1 enzyme digested products were separated on 2% agarose gel with 100 bp marker. 
Statistical Analysis
Allele frequency was determined by gene counting method.
Results and Discussion:
PCR amplification produced 310 bp long amplicon, which after digestion with TaqI produced 180bp and 130 bp long fragments in case of normal C allele (A2) and mutant T allele (A1) remain uncut after TaqI digestion ( Fig. 1 and 2) . In total 50 samples analyzed, normal homozygous genotype was found in 12, heterozygous genotype was observed in 32 and mutant homozygous genotype was observed in 6 individuals.
The C and T allele were found as 0.56 and 0.44 respectively (Table 2) . Four alleles (genetic variants) are reported at Taq1A locus referred to as A1 A2, A3 and A4.
Where A2 is the most common form and A3 and A4 are the rare variants [14] . DRD2gene
Taq1A polymorphism was very well studied in world's different populations [3, 5, 9, 15, 16] as well as in different Indian regions [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Various studies reported presence of A1 allele is significantly higher in certain drug of abuse such as alcoholism and other behavioural characteristics as well [28] . Here our report suggests that there is higher frequency of A2 allele in Jaunpur population. Our study is co-related with numerous studies from India where they also reported higher frequency of A2 allele in control population. Juyal et al. [26] studied South and North Indian population, worked on Parkinsons disease reported frequency of A2 allele to be 0.66 and A1 allele to be 0.33 in their control group. One other study of Kumudini et al. [29] studied South Indian population also found nearly the same result. They reported 0.68, A2 allele frequency and 0.31 A1 allele frequencies. However, few reports are also available that shows the higher frequency of A1 allele in control group. The report of Vijayan et al. [25] indicates the A2 allelic frequency is 0.34 and A1 allele is 0.65. Various international studies also report the higher prevalence of A2 allele in their control group. Alfimova et al. [5] stated A2 allele frequency to be of 0.80 and A1 allele to be of 0.19 in Moscow population. Another study on PTSD of Voisey et al. [15] of Australia studied control Caucasians reported A2 allele frequency 0.82 and A1 allelic frequency 0.17. Despite contradictory results were indicated by a study of China by Lee et al.
[16] worked on Tourette syndrome explored control group and reported 0.47 A2 allele frequency and 0.52 A1 allele frequency. Hence, these findings showing the variations in the allelic frequency suggest that prevalence of higher A2 allelic frequency can be population specific.
